VRAD Co. Ltd Launches Two Virtual Reality based Medical Stimulators

VRAD Co. Ltd Launches Two Virtual Reality based Medical Stimulators

Highlights

  • Immersive clinical simulation platform enabling users to perform clinical exercises with simulated patients in a virtual environment

VRAD Co., Ltd. is introducing two Korean-developed virtual reality simulators, NS_Core and IP_Trauma, to global markets. These simulators support various languages, including Korean, English, Vietnamese, Thai, Indonesian, Chinese, Japanese, Kazakh, and German, with Spanish and French set to follow by year-end.

NS_Core is a virtual reality simulation solution designed for nursing skill training using Meta’s headset. It enables users to practice clinical exercises with simulated patients, addressing challenges in hands-on training within nursing school curricula. Developed through collaboration between hospitals and universities, NS_Core allows intensive practice on 20 essential nursing skills to improve clinical performance.

IP_Trauma is a VR training platform aimed at enhancing trauma care skills in medical personnel. It focuses on teaching procedures, equipment use, situational assessment, decision-making, teamwork, and real-time communication. Created in partnership with Korean universities and hospitals, it adheres to globally recognised Advanced Trauma Life Support protocol standards and incorporates reactive scenario simulations.

The IP_Trauma simulator enables real-time communication between users, allowing them to practice trauma care techniques and critical decision-making in a virtual setting. It includes over 40 procedural steps, from pre-hospital preparation to patient transfer. Simulation managers can assign scenarios, give instructions, and guide participants during training.

VRAD, a leading VR medical technology provider in Korea, supplies its products to over 90 institutions worldwide.

Related post

AstraZeneca’s DatroWay Delivers Breakthrough in Advanced Breast Cancer Survival

AstraZeneca’s DatroWay Delivers Breakthrough in Advanced Breast Cancer Survival

Highlights: DatroWay, a new innovation by AstraZeneca, boosts survival odds among advanced breast cancer patients DatroWay utilises ADC that delivers high-precision…
What is the link between Long Covid and The Mysterious Brain Fog?

What is the link between Long Covid and The…

Highlights: AMPAR receptors may explain the onset of brain fog among those affected by long Covid AMPARs also provide explanation for…
Update on WHO’s Triple Billion Targets

Update on WHO’s Triple Billion Targets

Highlights: WHO progressing toward Triple Billion targets focused on health, UHC, and emergency protection 5 billion people expected to benefit by…